Abstract
We have evaluated the properties of a new class of anti-inflammatory agents derived from capsaicin, using the analogs NE-19550 (N-vanillyloleamide) and NE-28345 (N-oleyl-homovanillamide) as examples. This class displayed an atypical profile in the assays utilized, including 1) anti-edema and antileukocyte migration activity in the rat carrageenan pleurisy assay without suppression of pleural prostanoid synthesis, 2) blockade of human platelet aggregation induced by arachidonate or PAF but not that induced by the PGH2 analog U-46619, without equivalent inhibitionin vitro of mammalian cyclooxygenase or thromboxane synthetase preparations, 3) greater potency and efficacy in the rat implanted sponge assay than in the adjuvant arthritis assay, without inhibition of LTB4 or 15-HETE synthesisin vitro, 4) stronger topical activity in the mouse croton oil inflamed ear assay than the guinea pig UV erythema assay, and 5) oral activity in the rat carrageenan paw edema assay and mouse phenylquinone abdominal constriction rest combined with failure to induce gastric erosion in rats at therapeutic doses. We conclude that NE-19550 and NE-28345 do not act like conventional NSAIDs via suppression of arachidonic acid metabolism.
Similar content being viewed by others
References
R. J. Flower and J. R. Vane,Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol. Nature240, 410–411 (1972).
S. H. Ferreira, S. Moncada and J. R. Vane,Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis. Br. J. Pharmacol.47, 629P-630P (1973).
G. A. Higgs, R. J. Flower and J. R. Vane,A new approach to anti-inflammatory drugs. Biochem. Pharmacol.28, 1959–1961 (1979).
G. A. Higgs, K. G. Mugridge, S. Moncada and J. R. Vane,Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755c. Proc. Natl. Acad. Sci. USA81, 2890–2892 (1984).
E. Vallee, J. Gougat, J. Navarro and J. F. Delahayes,Anti-inflammatory and platelet anti-aggregant activity of phospholipase A 2 inhibitors. J. Pharm. Pharmacol.31, 588–592 (1979).
M. Fitzgerald,Capsaicin and sensory neurones—a review. Pain5,109–130 (1983).
T. R. Laflann and R. W. Farmer,Anti-nociceptive actions of capsaicin in rodents. Proc. West. Pharmacol. Soc.26, 145–149 (1983).
L. M. Brand, K. L. Skare, M. E. Loomans, M. L. Skoglund, H. H. Tai, C. Chiabrando and R. Fanelli,NE-19550, an anti-inflammatory analgesic with a novel mechanism. Fed. Proc.45, 334 (1986).
L. M. Brand, E. F. Berman, R. J. Schwen, M. E. Loomans, J. M. Janusz, R. Bohne, C. Maddin, J. Garnder, T. Leflann, R. Farmer, L. Jones, C. Chiabrando and R. Fenelli,NE-19550: a novel, orally active anti-inflammatory analgesic. Drugs Exptl. Clin. Res. XIII, 259–265 (1987).
F. E. Dewhirst,Structure-activity relationships for inhibition of prostaglandin cyclooxygenase by phenolic compounds. Prostaglandins20, 209–222 (1980).
H. Wagner, M. Wierer and R. Bauer,Anti-inflammatory drugs, part 3. In vitro inhibition of prostaglandin biosynthesis by essential oils and phenolic compounds. Planta Med.3, 184–187 (1986).
F. Kuichi, M. Shibuya and U. Sankawa,Inhibitors of prostaglandin biosynthesis from ginger. Chem. Pharm. Bull.30, 754–757 (1982).
D. L. Flynn, M. F. Rafferty and A. M. Boctor,Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukotrienes Med.24, 195–198 (1986).
S. Ikawami, S. Shibuya, C. F. Tseng, F. Hanoaka and U. Sankawa,Inhibition of arachidonate 5-lipoxygenase by phenolic compounds. Chem. Pharm. Bull.34, 3960–3963 (1986).
K. Miyaska and T. Mikami,Comparison of the antiinflammatory effects of dexamethasone, indomethacin and BW755c on carrageenan-induced pleurisy in rats. Eur. J. Pharmacol.77, 229–236 (1982).
K. E. Fahrenholz, M. Z. Silverweis, N. Germane, H. J. Crowley, D. A. Sinko and C. Dalton,3-Phenyl-5-[2,2,2-trifluoro-1-hydroxy(trifluoromethyl) ethyl]indole-2-carbonitrile, a potent inhibitor of prostaglandin synthetase and platelet aggregation. J. Med. Chem.22, 948–953 (1979).
C. Chiabrando, A. Noseda, M. N. Castagnoli, M. Salmona and R. Fanelli,Characterization of arachidonic acid metabolic profiles in animal tissues by high resolution gas chromatography-mass spectrometry. Biochim. Biophys. Acta794, 292–297 (1984).
H. H. Tai and B. Yuan,On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase. Biochem. Biophys. Res. Comm.80, 236–242 (1978).
G. C. Gairola and H. H. Tai,Cigarette smoke-induced alterations in the release of arachidonate metabolites by pulmonary alveolar macrophages from selenium-fed and selenium-deficient rats. Biochem. Pharmacol.35, 2423–2428 (1986).
A. Blackham, A. A. Norris and F. A. Woods,Models for evaluating the anti-inflammatory effects of inhibitors of arachidonic acid metabolism. J. Pharm. Pharmacol.37, 787–793 (1985).
Z. E. Mielens, K. Connoly and V. J. Stecher,Effect of disease-modifying antirheumatic drugs and nonsteroidal anti-inflammatory drugs upon cellular and fibronectin responses in a pleurisy model. J. Rheumatol.12, 1083–1087 (1985).
F. Lembeck and J. Donnerer,Time course of capsaicin-induced functional impairments in comparison with changes in neuronal substance P content. Naunyn Schmiedebergs Arch. Pharmacol.316, 240–243 (1981).
A. Saria, J. M. LUndberg, G. Skofitsch and F. Lembeck,Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotinin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch. Pharmacol.324, 212–218 (1983).
R. A. Karmali and B. Safai,Ultraviolet-evoked prostaglandin biosynthesis in varying stages of keratinocyte differentiation in guinea pig skin. Prostaglandins Leukotrienes Med.15, 277–286 (1984).
G. G. Moore and K. F. Swingle,2,6-Di-tert-butyl-4-(2-thenoyl)phenol (R-830): a novel non-steroidal anti-inflammatory agent with antioxidant properties. Agents and Actions12, 674–683 (1982).
R. Vinegar, J. F. Truax, J. L. Selph and F. A. Voelker,Pathway of onset, development and decay of carrageenan pleurisy in the rat. Fed. Proc.41, 2588–2595 (1982).
A. P. Green, F. R. Morgan, M. J. Thrompson, K. E. Randall and E. A. Boyle,BRL 20459, a novel topically active nonsteroidal anti-inflammatory drug. J. Pharm. Pharmacol.36, 314–317 (1984).
J. D. Levine, R. Clark, M. Devor, C. Helms, M. A. Moskowitz and A. I. Busbaum,Intraneuronal substance P contributes to the severity of experimental arthritis. Science226, 547–549 (1984).
M. Lotz, D. A. Carson and J. H. Vaughn,Substance P activation of rheumatic synoviocytes: neural pathway in the pathogenesis of arthritis. Science235, 893–895 (1987).
F. C. Colpaert, J. Donnerer and F. Lembeck,Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci.32, 1827–1834 (1983).
A. Hara, T. Sakurada, S. Sakurada, H. Matsumura, R. andoh and K. Kisara,Effects of capsaicin on adjuvant-induced chronic pain in rats. Ann. Rep. Tohoku Coll. Pharm.31, 153–159 (1984).
R. D. Inman, B. Chiu, S. Rabinovich and W. Marshall,Neuromodulation of synovitis capsaicin effect on severity of experimental arthritis. J. Neuroimmunol.24, 17–22 (1989).
F. Y. Lam and W. R. Ferrell,Capsaicin suppresses substance P-induced joint inflammation in the rat. Neuroscience Letters105, 155–158 (1989).
A. K. De and J. J. Ghosh,Inflammatory effects of acute and chronic capsaicin treatment on rat paw. Phytotherapy Research2, 175–179 (1988).
A. Saria,Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br. J. Pharmacol.82, 217–222 (1984).
J. P. Wang, M. F. Hsu and C. M. Teng,Antiplatelet effect of capsaicin. Thromb. Res.36, 497–507 (1984).
J. Maclouf, S. Levy-Toledano, E. Savariau, R. Hardisty and J. P. Chen,Arachidonic acid-induced platelet aggregation independent of cyclooxygenase and lipoxygenase. Prostaglandins28, 383–398 (1984).
T. J. Hallam, A. Sanchez and T. J. Rink,Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2. Biochem. J.218, 819–827 (1984).
D. Lauri, C. Carletti and G. deGaetano,Amplification of the primary response of human platelets to platelets activating factor: aspirin sensitive and aspirin-insensitive pathways. J. Lab. Clin. Med.105, 653–658 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brand, L.M., Skare, K.L., Loomans, M.E. et al. Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. Agents and Actions 31, 329–340 (1990). https://doi.org/10.1007/BF01997628
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01997628